Brokerages Set LHC Group, Inc. (NASDAQ:LHCG) Price Target at $122.09

Shares of LHC Group, Inc. (NASDAQ:LHCG) have been assigned an average recommendation of “Buy” from the fourteen research firms that are currently covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $122.09.

LHCG has been the topic of several analyst reports. UBS Group set a $133.00 price target on shares of LHC Group and gave the stock a “buy” rating in a research note on Friday, May 10th. Royal Bank of Canada lifted their price target on shares of NVIDIA to $200.00 and gave the stock an “outperform” rating in a research note on Monday, May 13th. Barclays reaffirmed a “hold” rating on shares of LHC Group in a research note on Sunday, May 12th. BidaskClub raised shares of Zai Lab from a “buy” rating to a “strong-buy” rating in a research note on Friday, June 28th. Finally, Jefferies Financial Group set a €28.00 ($32.56) price target on shares of Hamburger Hafen und Logistik and gave the stock a “buy” rating in a research note on Thursday, May 9th.

In other LHC Group news, COO Donald Dwayne Stelly sold 448 shares of the firm’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $120.00, for a total transaction of $53,760.00. Following the completion of the transaction, the chief operating officer now directly owns 91,252 shares of the company’s stock, valued at approximately $10,950,240. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Ronald T. Nixon sold 12,000 shares of the firm’s stock in a transaction on Wednesday, May 22nd. The stock was sold at an average price of $117.20, for a total transaction of $1,406,400.00. Following the transaction, the director now directly owns 29,100 shares of the company’s stock, valued at $3,410,520. The disclosure for this sale can be found here. Insiders have sold a total of 46,269 shares of company stock worth $5,314,613 in the last ninety days. 5.20% of the stock is currently owned by insiders.

A number of hedge funds have recently made changes to their positions in the business. BlackRock Inc. grew its holdings in LHC Group by 2.6% during the 1st quarter. BlackRock Inc. now owns 4,686,353 shares of the health services provider’s stock worth $519,530,000 after acquiring an additional 120,016 shares in the last quarter. FMR LLC boosted its holdings in shares of LHC Group by 2.4% in the 1st quarter. FMR LLC now owns 1,151,105 shares of the health services provider’s stock valued at $127,612,000 after buying an additional 27,272 shares during the period. Norges Bank acquired a new position in shares of LHC Group in the 4th quarter valued at about $51,535,000. Thrivent Financial for Lutherans boosted its holdings in shares of LHC Group by 9.1% in the 4th quarter. Thrivent Financial for Lutherans now owns 530,693 shares of the health services provider’s stock valued at $49,822,000 after buying an additional 44,450 shares during the period. Finally, OppenheimerFunds Inc. boosted its holdings in shares of LHC Group by 3.1% in the 1st quarter. OppenheimerFunds Inc. now owns 502,757 shares of the health services provider’s stock valued at $55,735,000 after buying an additional 15,013 shares during the period. 91.42% of the stock is owned by institutional investors.

Shares of LHCG stock traded up $0.11 during mid-day trading on Friday, reaching $124.89. The company’s stock had a trading volume of 9,350 shares, compared to its average volume of 218,043. The firm’s 50 day moving average is $117.00. LHC Group has a 12-month low of $80.84 and a 12-month high of $125.28. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.57 and a quick ratio of 1.57. The stock has a market cap of $3.91 billion, a price-to-earnings ratio of 34.83, a PEG ratio of 2.09 and a beta of 0.81.

LHC Group (NASDAQ:LHCG) last issued its earnings results on Wednesday, May 8th. The health services provider reported $0.98 EPS for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.08. LHC Group had a net margin of 3.83% and a return on equity of 8.43%. The business had revenue of $502.59 million for the quarter, compared to the consensus estimate of $511.16 million. On average, equities research analysts predict that LHC Group will post 4.3 EPS for the current fiscal year.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Featured Article: What are economic reports?

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.